Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
HCC1806 Cediranib
10.0
VEGFR/cKIT
RTK
 0.0954 0.27518
T47D Cediranib
0.01
VEGFR/cKIT
RTK
 1.0474 -0.00177
T47D Cediranib
0.1
VEGFR/cKIT
RTK
 1.0717 0.00087
T47D Cediranib
0.31623
VEGFR/cKIT
RTK
 0.9776 -0.00031
BT-549 Cediranib
0.1
VEGFR/cKIT
RTK
 0.9972 0.00050
PDX1258 Cediranib
0.01
VEGFR/cKIT
RTK
 1.0704 0.00840
MCF7 Cediranib
10.0
VEGFR/cKIT
RTK
 0.1149 0.16822
PDX1258 Cediranib
3.1623
VEGFR/cKIT
RTK
 0.9072 0.01811
PDX1258 Cediranib
0.0031623
VEGFR/cKIT
RTK
 1.1034 -0.00387
MDA-MB-436 Cediranib
0.31623
VEGFR/cKIT
RTK
 1.0266 -0.00386
HCC1806 Cediranib
0.0031623
VEGFR/cKIT
RTK
 1.0810 -0.01058
HCC1806 Cediranib
0.001
VEGFR/cKIT
RTK
 0.9923 0.00046
MCF 10A Cediranib
0.1
VEGFR/cKIT
RTK
 1.0093 -0.00083
HCC1806 Cediranib
0.01
VEGFR/cKIT
RTK
 1.0401 0.00080
MCF7 Cediranib
3.1623
VEGFR/cKIT
RTK
 0.7736 0.00746
BT-549 Cediranib
0.031623
VEGFR/cKIT
RTK
 1.0263 -0.00019
Hs 578T Cediranib
3.1623
VEGFR/cKIT
RTK
 0.1560 0.19759
Hs 578T Cediranib
1.0
VEGFR/cKIT
RTK
 0.3858 0.10669
MCF7 Cediranib
0.31623
VEGFR/cKIT
RTK
 0.9975 0.00032
MCF7 Cediranib
0.1
VEGFR/cKIT
RTK
 1.0382 -0.00225
MCF 10A Cediranib
0.0031623
VEGFR/cKIT
RTK
 1.0035 -0.00027
MCF 10A Cediranib
0.01
VEGFR/cKIT
RTK
 1.0016 -0.00009
Hs 578T Cediranib
0.31623
VEGFR/cKIT
RTK
 0.5611 0.05612
CAMA-1 Cediranib
0.1
VEGFR/cKIT
RTK
 1.0196 -0.00465
CAMA-1 Cediranib
0.031623
VEGFR/cKIT
RTK
 1.0356 -0.00480